During the third quarter, we installed two new ClearPoint sites, and in a strong start to the fourth quarter, we have already signed up two additional sites.
i understand your point of view but still think that the number of installs is preventing much needed growth for the disposable revenue to materialize. " The installs have doubled in 2 years". When you double from a small number the result is not a whole lot. IMO the install rate needs to be pumped up and then the disposable revenue will follow.
As i have stated in previous posts - it would help immensely if a drug such as aldoxorubicin cleared the FDA and could leverage this technology for the benefit of the patient. The adoption rate would hasten the process of growing revenue.
The installs have doubled in 2 years and the install trajectory will continue to the upside. But since the company operates using a razor/razor blade model, unless surgeons are pushing patients through ClearPoint at a decent clip they're not going to make the disposable revenue needed to grow. In other words, they could have their system in every hospital in the world but if the units are just collecting dust the company will languish will burning cash like crazy.
Pressure is building on the buy side. The nibblers are slowly accumulating. That's what I think. Need some more installs to get this going up...
perhaps GE new CT scanner with MRIC will help.
Sentiment: Strong Buy
I would agree. What is investor relations really going to say to questions like that? People just need to see an opportunity and be happy it presented itself.
not naming names, but we have a good one on this board....and it's not me.
Once they can get Neurologists 'sold' on the benefits; then things could happen quickly. Published results would then start to make the medical literature. And nobody will want to be left behind.
At present there is no interest in MRIC, all the better for us longs, since we can add at these low prices to our position.
MRIC's share price is at the same level as it was, prior to FG's appointment as CEO. Therefore, the Street does not give FG any credit for being able to turn thing around (meaning: better sales management...), which I think is plainly wrong. FG is not just the average guy, but someone with a proven track record to boost, having been partly responsible for one of the most exiting growth stories in Medtech (ISRG). And this guy comes now to MRIC thinking, there might be some potential in this nifty outfit. great potential. I guess MRIC was not the only job offer he had... Anyway, I, for one hear the music. Reassuringly, his remarks in the Q-PR were exactly like I hoped: no-nonsense, to the point, constructive, talking strategy without fuzzy words.
Now we have to wait for the results, which might take some time, although I a quite sure, that there is a lot of low hanging fruit out here....
So: relaaxxx, and enjoy....
BTW: If your question to IR was: "why does the share price tank?" or "why don't you do something about it?".... what do you figure those poor guys at IR should reply to you...?
Tired of sending irate emails to MRIC's Investor Relations (Oscar Thomas) because quite frankly they don't have a relationship with their investors. They don't respond to investors and we keep getting our A$$e$ handed to us. A lousy .80 a share, sickening.
I could be wrong but back in Q1 or 2 of 2013 I believe there was a licensing agreement with Boston Scientific.
Just recently they hired “medical device veteran Wendelin Maners in the role of Vice President, Marketing”. Previously she worked for Boston Scientific where she “developed and executed acquisition strategies”.
Maybe what we have been seeing recently is positioning for a buyout?
66000 shares equals 50-60K bucks. 290000 shares equals 250-300k bucks. No big money yet
PS: I m long an I quintupled my position over the past 6m or so...
Jcdean, Ive traded CYTR with good gains but you need to realize that company is not a good long term holding.
Go to the company site, Click on About US, Management Team, Scroll down to David J Haen.
He seems to be someone's son in law who just graduated from College!!!!
Its little tells like this that enable you to gauge a company,s real potential.
Let me reiterate, its a legitimate company with a drug candidate that looks promising. I have been long the stock multiple time.
I just dont see it as a long term holding. I always book my CYTR gains when I got em.
I'm long this stock but bought way too early (paid too much for it). Understand the technology and the success the trials are having. Potential is great for MRIC. This is the type of catalyst that we need to get this stock's potential realized. Word is out....
Although none of us can look clearly into a crystal ball it seems like some of the negativity on this board is unwarranted.
They absolutely needed money to put into place an agenda set forth by Frank.
Now they can move forward.
Honestly the fruits of these actions will hopefully be self evident sometime in 2015.
These technologies are exciting and have a lot of room to grow.
Give these guys some time to pull it together.